Ken Griffin
TRIB

Ken Griffin’s Trinity Biotech TRIB Stock Holding History

Ken Griffin’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.7K Sell
473
-404
-46% -$8.92K ﹤0.01% 12786
2025
Q4 		$20.8K Buy
+877
New +$25.9K ﹤0.01% 12337
2025
Q3 		– Sell
-443
Closed -$8.82K – 14136
2025
Q2 		$8.82K Sell
443
-447
-50% -$8.97K ﹤0.01% 12204
2025
Q1 		$15.2K Buy
+890
New +$21.1K ﹤0.01% 13330
2024
Q3 		– Sell
-72
Closed -$4.47K – 15269
2024
Q2 		$4.47K Buy
+72
New +$4.19K ﹤0.01% 13479
2024
Q1 		– Sell
-7
Closed -$429 – 15445
2023
Q4 		$429 Buy
+7
New +$501 ﹤0.01% 14030
2023
Q3 		– Sell
-29
Closed -$4.15K – 15120
2023
Q2 		$4.15K Sell
29
-10
-26% -$1.45K ﹤0.01% 13628
2023
Q1 		$5.45K Buy
+39
New +$6.03K ﹤0.01% 13871
2022
Q2 		– Sell
-116
Closed -$18K – 14117
2022
Q1 		$18K Sell
116
-11
-9% -$1.9K ﹤0.01% 13277
2021
Q4 		$27K Sell
127
-13
-9% -$3.69K ﹤0.01% 13510
2021
Q3 		$45K Sell
140
-191
-58% -$67.2K ﹤0.01% 13423
2021
Q2 		$146K Buy
331
+182
+122% +$90.8K ﹤0.01% 12533
2021
Q1 		$84K Buy
149
+35
+31% +$25.2K ﹤0.01% 12609
2020
Q4 		$65K Sell
114
-41
-26% -$20.4K ﹤0.01% 10463
2020
Q3 		$47K Buy
155
+27
+21% +$9.37K ﹤0.01% 9625
2020
Q2 		$42K Buy
+128
New +$29.3K ﹤0.01% 9381

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ken Griffin's TRIB Position: Q4 2025 in Review

Ken Griffin sold out of Trinity Biotech (TRIB) in Q4 2025, closing a stake of 1,313 shares — an estimated $38.7K sold.

Ken Griffin first reported a position in TRIB in Q4 2013 and held it in 21 quarters. The position peaked at $892K in Q1 2015. 25 funds tracked by Wall St. Rank hold TRIB as of Q4 2025.

  • Ken Griffin reported no remaining Trinity Biotech position as of Q4 2025 after selling out during the quarter.
  • Ken Griffin sold 1,313 Trinity Biotech shares in Q4 2025, an estimated $38.7K.
  • Ken Griffin first reported a position in Trinity Biotech in Q4 2013 and held it in 21 quarters.
  • Ken Griffin's Trinity Biotech position peaked at $892K in Q1 2015.
  • 25 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.